Legend Biotech annual current ratio
2019
2020
2021
2022
2023
2024
2025
Legend Biotech Current Ratio Growth & History (LEGN)
Legend Biotech's current ratio was 1.96 for fiscal 2025.
View full Legend Biotech company overviewLegend Biotech annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 1.96 | −2.66 | −57.61% |
| 2024 | 2024-12-31 | 4.62 | −2.30 | −33.20% |
| 2023 | 2023-12-31 | 6.92 | 3.23 | +87.51% |
| 2022 | 2022-12-31 | 3.69 | −0.45 | −10.94% |
| 2021 | 2021-12-31 | 4.14 | −1.00 | −19.37% |
| 2020 | 2020-12-31 | 5.14 | 3.52 | +217.05% |
| 2019 | 2019-12-31 | 1.62 | — | — |
Legend Biotech quarterly current ratio
Q4.19
Q4.20
Q2.21
Q4.21
Q4.22
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 3.04 | −1.67 | −35.40% |
| Q1 2026 | 2026-03-31 | 2.13 | −3.07 | −59.10% |
| Q4 2025 | 2025-12-31 | 1.96 | −2.66 | −57.61% |
| Q3 2025 | 2025-09-30 | 2.86 | −2.12 | −42.52% |
| Q2 2025 | 2025-06-30 | 4.71 | −0.13 | −2.76% |
| Q1 2025 | 2025-03-31 | 5.20 | −0.46 | −8.16% |
| Q4 2024 | 2024-12-31 | 4.62 | −2.30 | −33.20% |
| Q3 2024 | 2024-09-30 | 4.98 | −3.63 | −42.12% |
| Q2 2024 | 2024-06-30 | 4.84 | −3.17 | −39.55% |
| Q1 2024 | 2024-03-31 | 5.66 | — | — |
| Q4 2023 | 2023-12-31 | 6.92 | 3.23 | +87.51% |
| Q3 2023 | 2023-09-30 | 8.61 | — | — |
| Q2 2023 | 2023-06-30 | 8.01 | — | — |
| Q4 2022 | 2022-12-31 | 3.69 | −0.45 | −10.94% |
| Q4 2021 | 2021-12-31 | 4.14 | −1.00 | −19.37% |
| Q2 2021 | 2021-06-30 | 2.76 | — | — |
| Q4 2020 | 2020-12-31 | 5.14 | 3.52 | +217.05% |
| Q4 2019 | 2019-12-31 | 1.62 | — | — |
Legend Biotech current ratio trends
Over the last five fiscal years, Legend Biotech's current ratio decreased from 5.14 to 1.96, a change of −3.18. The latest reported quarter, Q2 2026, shows 3.04.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Legend Biotech source filings ↗